In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Mural Oncology plc (NASDAQ: MURA) closed at $2.04 in the last session, up 0.49% from day before closing price of $2.03. In other words, the price has increased by $0.49 from its previous closing price. On the day, 0.64 million shares were traded. MURA stock price reached its highest trading level at $2.04 during the session, while it also had its lowest trading level at $2.03.
Ratios:
We take a closer look at MURA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.90 and its Current Ratio is at 5.90. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.00.
On June 28, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $15.Rodman & Renshaw initiated its Buy rating on June 28, 2024, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 03 ’25 when Cutler Adam D. sold 7,148 shares for $2.09 per share. The transaction valued at 14,939 led to the insider holds 99,290 shares of the business.
Goodman Vicki L sold 5,036 shares of MURA for $10,475 on Nov 10 ’25. The Chief Medical Officer now owns 84,727 shares after completing the transaction at $2.08 per share. On Nov 03 ’25, another insider, Cutler Adam D., who serves as the Officer of the company, bought 7,148 shares for $2.09 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MURA now has a Market Capitalization of 35382752 and an Enterprise Value of -19941248.
Stock Price History:
The Beta on a monthly basis for MURA is 2.93, which has changed by -0.50487804 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, MURA has reached a high of $4.74, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -1.97%, while the 200-Day Moving Average is calculated to be -14.17%.
Shares Statistics:
According to the various share statistics, MURA traded on average about 163.97K shares per day over the past 3-months and 315200 shares per day over the past 10 days. A total of 17.32M shares are outstanding, with a floating share count of 15.92M. Insiders hold about 8.19% of the company’s shares, while institutions hold 38.72% stake in the company. Shares short for MURA as of 1763078400 were 417436 with a Short Ratio of 2.55, compared to 1760486400 on 425813. Therefore, it implies a Short% of Shares Outstanding of 417436 and a Short% of Float of 2.69.
Earnings Estimates
The stock of Mural Oncology plc (MURA) is currently being evaluated by 1.0 analysts who are actively contributing to its market rating.
Analysts are recommending an EPS of between -$5.66 and -$5.66 for the fiscal current year, implying an average EPS of -$5.66. EPS for the following year is -$0.39, with 1.0 analysts recommending between -$0.39 and -$0.39.
